Cabozantinib plus nivolumab showed a 71% response rate in FH-dRCC, extending efficacy beyond non-clear cell RCC. The study ...

Combined efficacy of chemotherapy and ultrasound found to elevate brain cancer survival by 40%, making medications work ...

Sequential therapy yields lower survival and response rates in upper tract urothelial carcinoma versus bladder cancer. Learn ...

Researchers have found in an observational study that breast cancer patients using proton pump inhibitors (PPIs) alongside ...

For patients with autoimmune vasculitides, mortality is on the decline in the U.S. but still remains elevated compared with the general population. These immunological disorders of inflammation of ...

A study of 6,800 colon cancer patients found those who took Ozempic or Mounjaro were more likely to survive the disease. It ...

Diabetes and cancer are two of the four major non-communicable diseases identified by WHO. Their relationship is multifaceted ...

Scientists have discovered a drug combo that may bypass tumor defenses, offering new hope for children with high-risk ...

“The dual function of MiTEs enables them to attack the tumor from multiple immune angles at once,” explains von Locquenghien.

Replacing just one portion of red meat for beans or pulses a week could help ward off potentially deadly gallbladder cancer , ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has ...

Diffuse large B-cell lymphoma (DLBCL) is an aggressive blood cancer that kills most untreated patients within one year. Standard CHOP chemotherapy improves five-year survival to 70%—still a ...